Keros Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Keros Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy (NCT07704099) | Keros Therapeutics, Inc. | 2026-09-14 |
| A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia). (NCT05927012) | Keros Therapeutics, Inc. | 2023-11-30 |
| A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study). (NCT05975905) | Keros Therapeutics, Inc. | 2023-10-17 |
Track Keros Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.